Skip to main content

Olga Maisterra Santos

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Olga Maisterra Santos

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Projects

MULTI-BIO-TARGETS: una nueva estrategia para el manejo de ictus combinando biomarcadores pronósticos y neuroprotectores

IP: Olga Maisterra Santos
Collaborators: Joan Montaner Villalonga, Anna Penalba Morenilla, Paula Garcia Rodriguez
Funding agency: Instituto de Salud Carlos III
Funding: 363907.5
Reference: PI18/00804
Duration: 01/01/2019 - 30/06/2023

Discovery and clinical usefulness of blood biomarkers in stroke-associated pneumonia. The PROteomics and Transcriptomics in lEUkocyte Subpopulations (PROTEUS) study

IP: Olga Maisterra Santos
Collaborators: Bustamante Rangel, Alejandro, Joan Montaner Villalonga, Anna Penalba Morenilla
Funding agency: Fundació La Marató de TV3
Funding: 191375
Reference: 20170630
Duration: 01/01/2018 - 31/12/2021

El uso de antidepresivos y su asociación con ictus, frecuencia de hospitalizaciones y mortalidad, en la población anciana

IP: Luisa Ibáñez Mora
Collaborators: Xavier Vidal Guitart, Maria Elena Ballarin Alins, Antonio San Jose Laporte, Olga Maisterra Santos, Mònica Sabaté Gallego, Lina Fernanda Camacho Arteaga, Lina Fernanda Camacho Arteaga
Funding agency: Instituto de Salud Carlos III
Funding: 45375
Reference: PI15/01429
Duration: 01/01/2016 - 30/11/2020

Estudio de la enfermedad cardiovascular silente en una cohorte de pacientes hipertensos y su relación con el riesgo de ictus

IP: Maria Pilar Delgado Martínez
Collaborators: Olga Maisterra Santos
Funding agency: Instituto de Salud Carlos III
Funding: 165770
Reference: PI10/00705
Duration: 01/01/2011 - 31/12/2014

Related news

The TOUCH MSCA-COFUND doctoral training programme, led by UAB and focusing on the field of mental health, has opened its first call for applications, offering 13 doctoral positions.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Related professionals

Marc-Enric Fernandez Exposito

Marc-Enric Fernandez Exposito

Tècnic/a Grau Superior
Unitat legal
Direcció Jurídica
Read more
Bernat Massó Carreras

Bernat Massó Carreras

Research technician
Reconstructive Surgery of the Locomotor System
Read more
Xavier Serra Ruiz

Xavier Serra Ruiz

Research technician
Physiology and Pathophysiology of the Digestive Tract
Read more
Gemma  Duarri Llado

Gemma Duarri Llado

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.